compound → HasProperty → unrelated
Typicality: 0.333
Saliency: 0.196
Facets 3
structurally 4 degree
to the copolymers of the invention 4 other
to imatinib 2 location
Open triples 1
compound → be → unrelated 8
Sentiment analysis
negative neutral positive
0.158 0.770 0.072
Other statistics
Raw frequency 8
Normalized frequency 0.196
Modifier score 0.500
Perplexity 326.695